ACOG · Alpha Cognition Inc. · Metrics
$8.91
+0.61 (+7.35%)
At close · Oct 27
Return incl. dividend (before tax)
Q1 2026 earnings call transcript
Market Cap
$194.48M
Shares
21.78M
Volume · Oct 27
152.6K
Avg daily vol (3M)
123.35K
ACOG metrics
75 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$8.91
Market cap
$194.48M
Price action
20 metricsPrice change (1W)
-2.4%
Price change (30D)
-3.5%
Price change (3M)
-3.3%
Price change (6M)
+29.1%
Price change (YTD)
+27.7%
Price change (1Y)
+20.8%
Trailing year
Price change (5Y)
—
52-week high
$9.75
52-week low
$4.50
Change from 52-week high
-14.9%
Change from 52-week low
+84.4%
Annualized volatility
63.1%
Annualized volatility (3M)
45.5%
Beta
1.1
RSI (14D)
40.5
Price vs SMA 50
-7.1%
Price vs SMA 200
+17.0%
Avg volume (3M)
122,662
Relative volume
0.7
Average dollar volume
$1.09M
Company
3 metricsSector
Healthcare
Industry
Biotechnology
Shares outstanding
21.78M
Valuation
12 metricsP / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
9.3×
reciprocal yield 10.7%
EV / EBITDA
—
EV / EBIT
—
P / sales
12.0×
reciprocal yield 8.3%
P / book
3.5
reciprocal yield 28.8%
FCF yield
-17.0%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-11.4%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-03-31
Profitability
9 metricsGross margin
94.1%
Operating margin
-174.7%
Trailing 12 months
Net margin
-137.7%
Gross profit (TTM)
$15.03M
Operating profit (TTM)
−$26.66M
Net income (TTM)
−$21.01M
Trailing 12 months
Diluted EPS (TTM)
$-0.97
FCF margin
-204.3%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+267.6%
Year over year
Net income growth YoY
—
Revenue (TTM)
$15.26M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+35.9%
Year over year · more shares
Revenue CAGR (3Y)
—
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
-39.7%
Return on assets
-32.6%
Debt / equity
0.0
Current ratio
9.0
EBITDA (TTM)
−$26.49M
Free cash flow (TTM)
−$31.18M
Quick ratio
8.0
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$41.38M
Latest balance sheet
Cash & equivalents
$41.38M
Total assets
$64.52M
Total debt
$0
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$30.85M
Capital expenditures (TTM)
$321,796
R&D (TTM)
$4.17M
SG&A (TTM)
$36.20M
Stock compensation (TTM)
$5.26M
R&D / revenue
27.3%
Stock compensation / revenue
34.5%
Ownership (13F)
9 metrics13F filers
26
13F filer change QoQ
+1
Institutional ownership
48.2%
Conviction holders (share of 13F filers)
3.8%
Crowding (high-turnover and private-fund holders)
47.0%
Private-fund adviser ownership
47.0%
Active holders' share change QoQ
-0.4%
Holder tenure
5.8
Price vs estimated holder cost
+18.7%
Ownership (registered funds)
1 metricsIndex-fund ownership
0.1%
Short interest
3 metricsShort interest
1.6%
Latest settlement · 3.8 days to cover
Days to cover
3.8d
Short-squeeze score
62 / 100
Insider activity
2 metricsNet insider buying (90D)
$96,200
Insider-sentiment score
81 / 100
Risk flags
1 metricsGoing concern
—